Patel Mahesh V.

Average Profitability
40.05%
Insider Buys Quantity
16
Insider Buys Sum
$477,749.37
Insider Sells Quantity
4
Insider Sells Sum
$147,952.65

Insider Activity of Patel Mahesh V.

The largest purchase of all time was on 2015-09-30 and amounted to 8000 shares of Lipocine Inc. for $94,709.

The largest sale of all time was on 2020-12-04 and amounted to 43500 shares of Lipocine Inc. for $68,134.

Biography of Patel Mahesh V.

No biography is available at this moment.

2023-05-25PurchaseLipocine Inc.
LPCN
CEO and President
8,706
0.1614%
$5.03$43,791-23.22%
2023-03-24PurchaseLipocine Inc.
LPCN
CEO and President
150,000
0.0107%
$0.32$48,000-21.17%
2023-03-17PurchaseLipocine Inc.
LPCN
CEO and President
50,000
0.0032%
$0.33$16,500-32.72%
2022-11-14PurchaseLipocine Inc.
LPCN
CEO and President
75,000
0.0051%
$0.39$29,250-23.3%
2022-09-27PurchaseLipocine Inc.
LPCN
CEO and President
100,000
0.0069%
$0.41$41,000-19.01%
2022-05-16PurchaseLipocine Inc.
LPCN
CEO and President
50,000
0.0032%
$0.77$38,495-39.62%
2021-11-18PurchaseLipocine Inc.
LPCN
CEO and President
25,000
0.0017%
$1.09$27,250-21.1%
2020-12-16SaleLipocine Inc.
LPCN
Chief Executive Officer
15,000
0.0013%
$1.35$20,250-1.45%
2020-12-04SaleLipocine Inc.
LPCN
Chief Executive Officer
43,500
0.004%
$1.57$68,134-11.04%
2019-12-31PurchaseLipocine Inc.
LPCN
CEO and President
40,000
0.0057%
$0.38$15,340+214.29%
2019-12-10PurchaseLipocine Inc.
LPCN
President and CEO
25,000
0.0036%
$0.40$9,975+143.65%
2019-12-04SaleLipocine Inc.
LPCN
CEO and President
43,500
0.0061%
$0.41$17,835+123.97%
2019-11-26PurchaseLipocine Inc.
LPCN
President and CEO
25,000
0.0036%
$0.43$10,696+113.06%
2019-11-18PurchaseLipocine Inc.
LPCN
CEO and President
50,000
0.0071%
$0.40$20,095+121.73%
2017-12-29SaleLipocine Inc.
LPCN
CEO, President
12,000
0.0036%
$3.48$41,734-59.3%
2015-09-30PurchaseLipocine Inc.
LPCN
President and CEO
8,000
0.0029%
$11.84$94,709-18.51%
2014-11-25PurchaseLipocine Inc.
LPCN
President and CEO
4,000
0.0019%
$5.10$20,400+52.3%
2014-11-24PurchaseLipocine Inc.
LPCN
President and CEO
4,000
0.002%
$5.45$21,800+47.18%
2014-11-14PurchaseLipocine Inc.
LPCN
President and CEO
4,000
0.0018%
$5.06$20,240+39.7%
2014-11-13PurchaseLipocine Inc.
LPCN
President and CEO
4,000
0.0019%
$5.05$20,208+48.99%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.